Related Experiment Video
Updated: Nov 6, 2025

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
Published on: February 28, 2021
SWI/SNF subunit BAF155 N-terminus structure informs the impact of cancer-associated mutations and reveals a potential
Mark D Allen1, Stefan M V Freund1, Mark Bycroft1,2
1UKRI MRC Laboratory of Molecular Biology, Cambridge, UK.
Abstract:
SWI/SNF (BAF) chromatin remodelling complexes are key regulators of gene expression programs, and attractive drug targets for cancer therapies. Here we show that the N-terminus of the BAF155/SMARCC1 subunit contains a putative DNA-binding MarR-like domain, a chromodomain and a BRCT domain that are interconnected to each other to form a distinct module. In this structure the chromodomain makes interdomain interactions and has lost its canonical function to bind to methylated lysines. The structure provides new insights into the missense mutations that target this module in cancer. This study also reveals two adjacent, highly-conserved pockets in a cleft between the domains that form a potential binding site, which can be targeted with small molecules, offering a new strategy to target SWI/SNF complexes.
Insights
The study reveals a new structural module in the BAF155/SMARCC1 protein, crucial for SWI/SNF (BAF) chromatin remodellers. This finding offers a novel strategy for small molecule drug development targeting cancer therapies.
Area of Science:
- Molecular Biology
- Structural Biology
- Cancer Therapeutics
Background:
- SWI/SNF (BAF) chromatin remodelling complexes regulate gene expression.
- These complexes are significant targets for cancer drug development.
Purpose of the Study:
- To elucidate the structure and function of the N-terminus of the BAF155/SMARCC1 subunit.
- To identify potential small molecule binding sites for therapeutic targeting.
Main Methods:
- X-ray crystallography to determine the 3D structure of the BAF155/SMARCC1 N-terminal module.
- Bioinformatic analysis to identify conserved domains and potential binding pockets.
Main Results:
- The N-terminus of BAF155/SMARCC1 forms a distinct module comprising MarR-like, chromodomain, and BRCT domains.
- The chromodomain engages in interdomain interactions, losing its typical methylated lysine binding function.
- Two adjacent, conserved pockets forming a potential small molecule binding site were identified.
Conclusions:
- The identified structural module and binding site offer new insights into cancer-associated mutations.
- This provides a novel strategy for developing small molecule inhibitors targeting SWI/SNF complexes in cancer therapy.
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...

